Therefore, to directly evaluate the effect of the drug treatment on existing melanoma cells in the brain, we developed a melanoma brain tumor model whereby YUMM3.2;Pten−/−;Akt1E17K cells were intracranially injected into newborn glowing head C57BL/6 mice28 (Figure 5A). This evidence concerns the gene PTEN and melanoma.